Computer-aided identification of dengue virus NS2B/NS3 protease inhibitors: an integrated molecular modelling approach for screening of phytochemicals
IU Mufti, M Sufyan, I Shahid, AR Alzahrani… - Journal of …, 2023 - Taylor & Francis
Globally, dengue (DENV) fever has appeared as the most widespread vector-borne disease,
affecting more than 100 million individuals annually. No approved anti-DENV therapy or …
affecting more than 100 million individuals annually. No approved anti-DENV therapy or …
Computer-aided identification of dengue virus NS2B/NS3 protease inhibitors: an integrated molecular modelling approach for screening of phytochemicals.
IU Mufti, M Sufyan, I Shahid, AR Alzahrani… - … Structure & Dynamics, 2023 - europepmc.org
Globally, dengue (DENV) fever has appeared as the most widespread vector-borne disease,
affecting more than 100 million individuals annually. No approved anti-DENV therapy or …
affecting more than 100 million individuals annually. No approved anti-DENV therapy or …
Computer-aided identification of dengue virus NS2B/NS3 protease inhibitors: an integrated molecular modelling approach for screening of phytochemicals
IU Mufti, M Sufyan, I Shahid… - … structure & dynamics - pubmed.ncbi.nlm.nih.gov
Globally, dengue (DENV) fever has appeared as the most widespread vector-borne disease,
affecting more than 100 million individuals annually. No approved anti-DENV therapy or …
affecting more than 100 million individuals annually. No approved anti-DENV therapy or …
[PDF][PDF] Computer-aided identification of dengue virus NS2B/NS3 protease inhibitors: an integrated molecular modelling approach for screening of phytochemicals
IU Mufti, M Sufyan, I Shahid, AR Alzahrani, N Shahzad… - researchgate.net
Globally, dengue (DENV) fever has appeared as the most widespread vector-borne disease,
affecting more than 100 million individuals annually. No approved anti-DENV therapy or …
affecting more than 100 million individuals annually. No approved anti-DENV therapy or …